Public Calendar: January 10 - 16, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 01/12/2021
Location: Virtual
Subject: COVID-19 Vaccines
FDA Participant/Group: BETH FRITSCH; JULIA TIERNEY; DAYLE CRISTINZIO; LORRIE MCNEILL; PETER MARKS; KEAGAN LENIHAN;
Non FDA Participant/Group: Several pediatric community stakeholders

Event Date: 01/15/2021
Location: Virtual
Subject: COVID-19 Vaccines Update: FDA and CDC Leadership Address the Rare Disease Community
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several rare disease community stakeholders

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 01/10/2021
Location: Virtual
Subject: Centers of Excellence in Regulatory Science and Innovation (CERSI) Summit 2021; Innovations in Regulatory Science Panel - Pandemic Preparedness: Lessons Learned from COVID-19
FDA Participant/Group: WILLIAM SLIKKER; JEFFREY SHUREN;
Non FDA Participant/Group: Academia, Indsutry, and other stakeholders

Event Date: 01/14/2021
Location: Virtual
Subject: National Academy of Medicine: Digital Health Sector Author Call
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/12/2021
Location: Virtual
Subject: Adult Vaccines Access Coalition; COVID-19 Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, advocates, and other stakeholders

Event Date: 01/14/2021
Location: Virtual
Subject: BioNJ / Sino-American Pharmaceutical Professionals Association (SAPA); The Regulatory Environment in the US
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and other stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 01/13/2021
Location: Virtual
Subject: Robotic Assisted Surgery
FDA Participant/Group: BINITA ASHAR; WILLIAM MAISEL;
Non FDA Participant/Group: Mark Leahey (Medical Device Manufacturers Association);

Event Date: 01/15/2021
Location: Virtual
Subject: Export Certificates
FDA Participant/Group: RENEE BEAVER; ELI TOMAR; CESAR PEREZ; ELLEN FLANNERY; LOUISE HOWE; SEAN BOYD; JESSICA RITSICK; MICHAEL RYAN;
Non FDA Participant/Group: Zach Rothstein, Janet Trunzo, Steve Silverman (AdvaMed);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: James Lawrence, J.D., Chief Counsel

No Significant Event